Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News BioLineRx Ltd. BLRX

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the...


Recent & Breaking News (NDAQ:BLRX)

BLRX Investors Have Opportunity to Lead BioLineRx Ltd. Securities Fraud Lawsuit

PR Newswire 6 hours ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire 7 hours ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

Newsfile 2 days ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

Newsfile 4 days ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire 6 days ago

BioLineRx Ltd. (BLRX) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioLineRx Ltd.

Business Wire 7 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

PR Newswire 7 days ago

BLRX Investors Have Opportunity to Lead BioLineRx Ltd. Securities Fraud Lawsuit

PR Newswire 9 days ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

Newsfile 10 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

Newsfile 10 days ago

Bronstein, Gewirtz & Grossman, LLC Notifies BioLineRx Ltd. (BLRX) Investors of Class Action and to Actively Participate

Business Wire 10 days ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd. (BLRX)

Business Wire 10 days ago

Bronstein, Gewirtz & Grossman, LLC Notifies BioLineRx Ltd. (BLRX) Investors of Class Action and to Actively Participate

Business Wire January 13, 2023

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd. (BLRX)

Business Wire January 13, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Newsfile January 13, 2023

BLRX NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire January 12, 2023

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd. (BLRX) Investors

Business Wire January 12, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Newsfile January 12, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

PR Newswire January 12, 2023

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd. (BLRX) Investors

Business Wire January 11, 2023